Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

CVS' Health Services segment posts $43B in revenues as specialty pharmacy and Caremark deals drive 2025 growth prospects.

The healthcare sector is dominated by massive players, but few are as influential as UnitedHealth Group Incorporated UNH and ...

A survey by PSG has found that the pressure to control drug costs is leading some payers to look into unbundling pharmacy ...

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...

CVS Caremark is the plan’s pharmacy benefit manager ... the manufacturer of GLP-1s Wegovy and Saxenda. That saved the state $539 off the $1,347 list price for each prescription of both drugs ...

A roundup of the most newsworthy healthcare press releases from PR Newswire, including Sanofi's $20B investment, Novo Nordisk's new initiatives for ...

Earlier this month, Novo announced that CVS Caremark chose Wegovy to be its preferred GLP-1 medication for obesity and weight-loss. 2 This policy will go into effect at the start of July. In a press ...

Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...